Dr Jitendra Singh announces soft launch of first indigenous antibiotic, Nafithromycin, to combat AMR

The development of Nafithromycin represents 14 years of research and an investment of ₹500 crores, with clinical trials spanning the US, Europe, and India
The post Dr Jitendra Singh announces soft launch of first indigenous antibiotic, Nafithromycin, to combat AMR appeared first on Express Healthcare.